What is the Centers for Medicare and Medicaid Services’ New AHEAD Model?
In September 2023, the Centers for Medicare and Medicaid Services (CMS) announced a new opportunity for states to leverage federal funding on health care: the Advancing All-Payer Health Equity...
View ArticleWhat to Know About the FDA’s Recent Decision to Allow Florida to Import...
Florida’s plan to import certain prescription drugs from Canada represents the first time the Food and Drug Administration (FDA) has granted authority for a state to safely import prescription drugs...
View ArticleFlorida’s Plan to Import Prescription Drugs from Canada, the First of its...
A new KFF policy watch explains some of the hurdles the state of Florida still must clear before it can implement its novel plan to make some prescription drugs more affordable by importing them from...
View Article10 Reasons Why Medicare Advantage Enrollment is Growing and Why It Matters
This issue briefs lays out 10 reasons why Medicare Advantage enrollment has been growing and why we can expect more growth in the years to come.
View ArticleHow Does Use of Medicaid Wraparound Services by Dual-Eligible Individuals...
This issue brief describes the share of dual-eligible individuals with full Medicaid benefits who use wraparound services, including institutional LTSS, home- and community-based services (HCBS),...
View ArticleFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
The Centers for Medicare & Medicaid Services (CMS) recently issued initial guidance describing CMS’s plans for implementation of the new Medicare Drug Price Negotiation Program, which was...
View Article3 Charts: Medicare Drug Price Negotiations
Under the Inflation Reduction Act, the federal government for the first time will negotiate directly with drug companies to determine the prices that Medicare will pay for certain high expenditure...
View ArticleIncome and Assets of Medicare Beneficiaries in 2023
This brief examines the income, assets, and home equity of Medicare beneficiaries, overall and by age, race and ethnicity, and gender, using data derived from the Dynamic Simulation of Income Model...
View ArticleLow Incomes, Little Savings: Many Medicare Beneficiaries Have Modest...
A new KFF analysis shows that most Medicare beneficiaries live on relatively low incomes and have modest financial resources for retirement – posing a risk to their economic well-being, particularly if...
View ArticleCommercialization of COVID-19 Vaccines, Treatments, and Tests: Implications...
With the depletion of the federal-purchased supply of COVID-19 vaccines, treatments and tests following the end of the public health emergency, this resource provides an overview of the implications of...
View ArticleMillions of People with Medicare Will Benefit from the New Out-of-Pocket Drug...
In 2025, Medicare beneficiaries will pay no more than $2,000 out of pocket for prescription drugs covered under Part D, Medicare’s outpatient drug benefit, due to a provision in the Inflation Reduction...
View ArticleNew $2,000 Medicare Part D Cap Could Reduce Out-of-Pocket Drug Costs for Over...
A KFF analysis shows that a new out-of-pocket spending cap in Medicare Part D could translate into savings for well over 1 million beneficiaries when it takes effect next year, including more than...
View Article10 Things to Know About Medicare Advantage Dual-Eligible Special Needs Plans...
In 2023, 5.2 million dual-eligible individuals were enrolled in a Medicare Advantage plan designed specifically for dual-eligible individuals, known as Dual-Eligible Special Needs Plans (D-SNPs). This...
View ArticleWhat to Know About How Medicare Pays Physicians
In November 2023, CMS finalized a 3.4% decrease in the physician fee schedule conversion factor, a key aspect of payment rates under the Medicare program, resulting in a 1.25% decrease in overall...
View ArticleFAQs on Prescription Drug Importation
These FAQs address questions related to prescription drug importation, including the current status of importation proposals, details of Florida’s importation program recently authorized by the FDA,...
View ArticleMedicare Households Spend More on Health Care Than Other Households
This brief examines the financial burden of health care spending among households where all members are covered by Medicare compared to non-Medicare households.
View ArticleMedicare Spending on Ozempic and Other GLP-1s Is Skyrocketing
This policy watch analyzes the latest data on Medicare Part D spending on GLP-1 drugs, initially approved to treat diabetes but in high demand as treatments for obesity, and shows how spending on these...
View ArticleGross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing –...
A KFF analysis shows that gross total Medicare spending on Ozempic and other similar drugs has increased dramatically in recent years – even though Medicare is explicitly prohibited by law from...
View ArticleGaps in Medicare Advantage Data Remain Despite CMS Actions to Increase...
The Centers for Medicare and Medicaid Services has recently taken actions to increase transparency in Medicare Advantage, however substantial data gaps remain that limit the ability of policymakers and...
View ArticleRetiree Health Benefits: Going, Going, Nearly Gone?
This data note analyzes five national surveys to assess trends in retiree health coverage among people ages 65 and older. These five surveys produce somewhat different estimates of retiree health...
View Article